Adjunctive stent use during endovascular intervention to the femoropopliteal artery with drug coated balloons: Insights from the XLPAD registry
Damianos G. Kokkinidis(Memorial Hospital of South Bend), Ehrin J. Armstrong(University of Denver), Subhash Banerjee(Baylor University Medical Center), Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), Haekyung Jeon‐Slaughter(Southwestern Medical Center), Nicolas W. Shammas(Midwest Cardiovascular Research Foundation), Houman Khalili
Cited by 16
Related Papers
<i>TRAF1–C5</i> as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
|New England Journal of Medicine|2007|830
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|Circulation|2019|433
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Outcomes After Complete Versus Incomplete Revascularization of Patients With Multivessel Coronary Artery Disease
|Journal of the American College of Cardiology|2013|389